Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_13266 | 49 | 1.03 | Mlig455_027179 | Neo: - Age: Down-Up-Down |
Mlig455_027179 {REF} {Length: 704} {RNA1310_72558} {RNA815_28618} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.992 | 1.511 | 0.99976 | 1.00000 | |
RegionR2 | 1.99 | 1.511 | 0.56876 | 0.92979 | |
RegionR3 | 4.416 | 1.511 | 0.13256 | 0.62470 | |
RegionR4 | 1.384 | 1.511 | 0.49503 | 0.82177 | |
RegionR5 | 1.362 | 1.511 | 0.38726 | 0.74279 | |
RegionR6 | -1.648 | 1.511 | 1.00000 | 1.00000 | |
RegionR7 | -2.209 | 1.511 | 1.00000 | 1.00000 | |
RegionR8 | -2.303 | 1.511 | 0.99932 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.217 | 1.511 | 0.99983 | 1.00000 | |
RegenerationR2 | -0.534 | 1.511 | 0.79071 | 0.98675 | |
RegenerationR3 | 0.148 | 1.511 | 0.84950 | 0.99818 | |
RegenerationR4 | -0.809 | 1.511 | 0.79323 | 0.98478 | |
RegenerationR5 | 0.463 | 1.511 | 0.98196 | 1.00000 | |
RegenerationR6 | 1.761 | 1.511 | 0.49813 | 0.80496 | |
RegenerationBL | -0.759 | 1.511 | 1.00000 | 1.00000 | |
RegenerationTP | 2.654 | 1.511 | 0.58808 | 0.95423 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_13266 | 49 | 1.03 | Mlig455_027179 | Neo: - Age: Down-Up-Down |
5 | - | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_027179 {REF} {Length: 704} {RNA1310_72558} {RNA815_28618} | |
2. | MligTC455_53396 | 62 | 1.28 | Mlig455_015104 | Neo: - Age: Down-Up-Down Region-enriched R3: 5.872/0.01335 |
2.841 | - | 0.903 | - | - | 0.960 | 0.978 | Mlig455_015104 {REF} {Length: 524} {RNA1310_47413} {RNA815_29456.2} | |
3. | MligTC455_22399 | 3614 | 75.29 | Mlig455_049143 | Neo: - Age: Down-Down-Up Region-enriched R3: 6.448/0.00000 |
2.789 | - | 0.947 | - | - | 0.954 | 0.888 | Mlig455_049143 {REF} {Length: 1035} {RNA1509_3861, RNA1509_6763} {RNA1310_46088, RNA1509_3861} {RNA1509_3861, RNA815_22985} | |
4. | MligTC455_36286 | 2583 | 53.81 | Mlig455_049146 | Neo: - Age: Down-Down-Up Region-enriched R3: 6.207/0.00000 |
2.722 | - | 0.954 | - | - | 0.961 | 0.807 | Mlig455_049146 {REF} {Length: 746} {Pfam: CUB domain [PF00431.22, score=28.0]} {RNA1509_1672} {RNA1310_53620, RNA1509_1672} {RNA1509_1672, RNA815_26829} | |
5. | MligTC455_47755 | 718 | 14.95 | Mlig455_015222 | Neo: - Age: Down-Up-Down Region-specific R3: 5.936 Region-enriched R3: 5.432/0.00000 |
2.706 | - | 0.876 | - | - | 0.856 | 0.974 | Mlig455_015222 {REF} {Length: 799} {RNA1509_23394} {RNA1310_55274.1, RNA1509_23394} {RNA1509_23394, RNA815_31503.1} | |
6. | MligTC455_26653 | 3263 | 67.97 | Mlig455_049144, Mlig455_049196 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.518 Region-specific R3: 7.699 Region-enriched R3: 6.693/0.00000 |
2.693 | - | 0.951 | - | - | 0.962 | 0.780 | Mlig455_049144 {REF} {Length: 862} {Pfam: CUB domain [PF00431.22, score=21.5]} {RNA1509_5316} {RNA1310_45244} {RNA815_23025} Mlig455_049196 {REF} {Length: 3464} {Pfam: CUB domain [PF00431.22, score=21.5]} {RNA1509_23994, RNA1509_5316} {RNA1310_45244, RNA1509_23994, RNA1509_5316} {RNA1509_23994, RNA1509_5316, RNA815_23025} |
|
7. | MligTC455_21467 | 816 | 17 | Mlig455_058500, Mlig455_058506 | Neo: - Age: Down-Up-Down Region-enriched R3: 4.231/0.00018 |
2.68 | - | 0.833 | - | - | 0.858 | 0.989 | Mlig455_058500 {REF} {Length: 466} {RNA1509_55725} {RNA1310_68398} {RNA815_42823} Mlig455_058506 {REF} {Length: 760} {RNA1509_55725} {RNA1310_68398, RNA1509_55725} {RNA1509_55725, RNA815_49141} |
|
8. | MligTC455_36020 | 1311 | 27.3 | Mlig455_018390 | Neo: - Age: Down-Down-Up Region-enriched R3: 5.222/0.00000 |
2.66 | - | 0.952 | - | - | 0.902 | 0.806 | Mlig455_018390 {REF} {Length: 1439} {RNA1509_748} {RNA1310_90094, RNA1509_748} {RNA1509_748, RNA815_23687} | |
9. | MligTC455_43193 | 359 | 7.49 | Mlig455_033211 | Neo: - Age: - |
2.657 | - | 0.943 | - | - | 0.982 | 0.732 | Mlig455_033211 {REF} {Length: 280} {NoTransDecoderORF} {RNA1310_121983} | |
10. | MligTC455_23202 | 2035 | 42.39 | Mlig455_049148, Mlig455_049198 | Neo: - Age: Down-Down-Up Region-enriched R3: 7.168/0.00000 |
2.646 | - | 0.933 | - | - | 0.963 | 0.750 | Mlig455_049148 {REF} {Length: 686} {Pfam: CUB domain [PF00431.22, score=29.6]} {Celegans: WBGene00008596, clec-54, C-type LECtin, [Score=44.3, Expect=1e-05]} {RNA1509_15319, RNA1509_26181} {RNA1310_56206, RNA1509_15319, RNA1509_26181} {RNA1509_15319, RNA1509_26181, RNA815_28296} Mlig455_049198 {REF} {Length: 687} {Pfam: CUB domain [PF00431.22, score=29.3]} {Celegans: WBGene00008596, clec-54, C-type LECtin, [Score=44.3, Expect=1e-05]} {RNA1509_29109} {RNA1310_56206, RNA1509_29109} {RNA1509_29109, RNA815_28296} |
|
11. | MligTC455_04170 | 65 | 1.36 | Mlig455_000555, Mlig455_030353 | Neo: - Age: - |
FGG | 2.588 | - | 0.895 | - | - | 0.963 | 0.730 | Mlig455_000555 {REF} {Length: 1133} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=125.0]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=103, Expect=3e-24]; ENSG00000120332, TNN, tenascin N, [Score=98.2, Expect=3e-22]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=102, Expect=6e-25]; ENSMUSG00000026938, Fcna, ficolin A, [Score=99.4, Expect=1e-23]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=98.2, Expect=9e-23]; ENSMUSG00000026725, Tnn, tenascin N, [Score=98.2, Expect=2e-22]} {Dmel: FBgn0051832, CG31832, [Score=88.2, Expect=2e-20]} {Celegans: WBGene00020516, T15B7.1, [Score=62.4, Expect=8e-11]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=72.4, Expect=4e-14]} {RNA1310_33683.2} {RNA815_41841} Mlig455_030353 {REF} {Length: 1214} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=126.3]} {Human: ENSG00000171557, FGG, fibrinogen gamma chain, [Score=103, Expect=3e-24]; ENSG00000120332, TNN, tenascin N, [Score=99.4, Expect=3e-22]; ENSG00000160339, FCN2, ficolin 2, [Score=98.2, Expect=6e-23]} {Mouse: ENSMUSG00000026835, Fcnb, ficolin B, [Score=102, Expect=1e-24]; ENSMUSG00000026938, Fcna, ficolin A, [Score=100, Expect=1e-23]; ENSMUSG00000026725, Tnn, tenascin N, [Score=99.0, Expect=2e-22]; ENSMUSG00000033860, Fgg, fibrinogen gamma chain, [Score=99.0, Expect=9e-23]} {Dmel: FBgn0051832, CG31832, [Score=92.0, Expect=9e-22]} {Celegans: WBGene00020516, T15B7.1, [Score=63.2, Expect=4e-11]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=75.9, Expect=4e-15]} {RNA1310_33683.2} {RNA815_41841} |
12. | MligTC455_10599 | 140 | 2.91 | Mlig455_000565, Mlig455_030365, Mlig455_030412 | Neo: - Age: logFC(26M/2M)=-0.762 |
GRIK3 | 2.588 | - | 0.860 | - | - | 0.960 | 0.768 | Mlig455_000565 {REF} {Length: 2846} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=72.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=56.1]; Ligand-gated ion channel [PF00060.28, score=44.5]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=145, Expect=3e-35]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=142, Expect=3e-34]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=141, Expect=5e-34]; ENSG00000105737, GRIK5, glutamate ionotropic receptor kainate type subunit 5, [Score=139, Expect=3e-33]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=144, Expect=5e-35]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=143, Expect=1e-34]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=140, Expect=9e-34]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=139, Expect=2e-33]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=138, Expect=5e-33]; ENSMUSG00000025892, Gria4, glutamate receptor, ionotropic, AMPA4 (alpha 4), [Score=138, Expect=4e-33]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=130, Expect=1e-30]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=135, Expect=3e-32]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=154, Expect=2e-38]} {RNA1509_59839} {RNA1310_4586} {RNA815_2154.1} Mlig455_030365 {REF} {Length: 2765} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=72.6]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=57.7]; Ligand-gated ion channel [PF00060.28, score=43.6]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=144, Expect=6e-35]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=140, Expect=2e-33]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=138, Expect=7e-33]; ENSG00000149403, GRIK4, glutamate ionotropic receptor kainate type subunit 4, [Score=138, Expect=7e-33]; ENSG00000105737, GRIK5, glutamate ionotropic receptor kainate type subunit 5, [Score=137, Expect=2e-32]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=142, Expect=2e-34]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=142, Expect=2e-34]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=138, Expect=4e-33]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=136, Expect=2e-32]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=136, Expect=2e-32]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=130, Expect=6e-31]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=131, Expect=3e-31]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=155, Expect=7e-39]} {RNA1509_59839} {RNA1310_4586} {RNA815_2154.1} Mlig455_030412 {REF} {Length: 2615} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=72.2]; Ligand-gated ion channel [PF00060.28, score=45.1]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=36.1]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=125, Expect=6e-29]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=122, Expect=6e-28]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=121, Expect=1e-27]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=125, Expect=4e-29]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=124, Expect=6e-29]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=120, Expect=2e-27]} {Dmel: FBgn0026255, clumsy, [Score=117, Expect=9e-27]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=117, Expect=7e-27]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=135, Expect=1e-32]} {RNA1509_59839} {RNA1310_4586} {RNA815_2154.1} |
13. | MligTC455_10597 | 50 | 1.03 | Mlig455_000567 | Neo: - Age: - |
GRIK3 | 2.584 | - | 0.986 | - | - | 0.833 | 0.765 | Mlig455_000567 {REF} {Length: 3419} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=70.9]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=51.0]; Ligand-gated ion channel [PF00060.28, score=43.2]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=148, Expect=5e-36]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=145, Expect=3e-35]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=141, Expect=8e-34]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=146, Expect=1e-35]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=145, Expect=2e-35]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=144, Expect=8e-35]} {Dmel: FBgn0039916, Ekar, Eye-enriched kainate receptor, [Score=131, Expect=4e-31]} {Celegans: WBGene00001614, glr-3, GLutamate Receptor family (AMPA), [Score=134, Expect=4e-32]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=148, Expect=1e-36]} {RNA1509_59839} {RNA1310_4586, RNA1509_59839} {RNA1509_59839, RNA815_2154.1} |
14. | MligTC455_33878 | 51 | 1.06 | Mlig455_060557 | Neo: - Age: Up-Down-Down |
PKD1L1 | 2.57 | - | - | 0.868 | - | 0.976 | 0.726 | Mlig455_060557 {REF} {Length: 10235} {Pfam: Polycystin cation channel [PF08016.14, score=213.7]; PLAT/LH2 domain [PF01477.25, score=42.6]} {Human: ENSG00000158683, PKD1L1, polycystin 1 like 1, transient receptor potential channel interacting, [Score=161, Expect=2e-39]; ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=157, Expect=2e-38]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=195, Expect=3e-50]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=89.0, Expect=1e-17]} {Celegans: WBGene00004035, pkd-2, Polycystin-2, [Score=117, Expect=7e-27]} {Smed: dd_Smed_v6_15525_0_1, dd_Smed_v6_15525_0_1, [Score=306, Expect=9e-87]} {RNA1509_40400} {RNA1310_24325} {RNA815_27769} |
15. | MligTC455_20532 | 63 | 1.32 | Mlig455_029971 | Neo: - Age: - |
2.506 | - | - | 0.769 | - | 0.950 | 0.787 | Mlig455_029971 {REF} {Length: 1702} {Pfam: UPF0489 domain [PF12640.9, score=20.3]} {RNA1509_3030} {RNA1310_35103} {RNA815_26539} | |
16. | MligTC455_45517 | 5935 | 123.64 | Mlig455_019215 | Neo: - Age: logFC(26M/2M)=0.286 Region-enriched R3: 6.104/0.00000 |
1.92 | - | - | - | - | 0.956 | 0.964 | Mlig455_019215 {REF} {Length: 894} {RNA1509_2707, RNA1509_2771} {RNA1310_17478.1, RNA1509_2707, RNA1509_2771} {RNA1509_2707, RNA1509_2771, RNA815_12018.1} | |
17. | MligTC455_45518 | 6058 | 126.2 | Mlig455_035564 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.828 Region-enriched R3: 6.058/0.00000 |
1.92 | - | - | - | - | 0.956 | 0.964 | Mlig455_035564 {REF} {Length: 516} {RNA1509_2707} {RNA1310_17478.1} {RNA815_12018.1} | |
18. | MligTC455_13098 | 19 | 0.4 | Mlig455_020992 | Neo: - Age: - |
C1GALT1 | 1.916 | - | - | - | - | 0.944 | 0.972 | Mlig455_020992 {REF} {Length: 1108} {Pfam: Galactosyltransferase [PF01762.23, score=27.6]} {Human: ENSG00000106392, C1GALT1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=160, Expect=3e-46]} {Mouse: ENSMUSG00000042460, C1galt1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1, [Score=162, Expect=1e-46]} {Dmel: FBgn0032078, C1GalTA, Core 1 Galactosyltransferase A, [Score=138, Expect=8e-38]} {Celegans: WBGene00008019, C38H2.2, Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=165, Expect=4e-48]} {Smed: dd_Smed_v6_4310_0_1, dd_Smed_v6_4310_0_1, [Score=185, Expect=3e-56]} {RNA1310_125941} |
19. | MligTC455_18395 | 39 | 0.8 | Mlig455_053780 | Neo: - Age: - |
MECOM | 1.909 | - | - | - | - | 0.946 | 0.963 | Mlig455_053780 {REF} {Length: 1146} {Pfam: Zinc-finger double domain [PF13465.8, score=63.0]; Zinc finger, C2H2 type [PF00096.28, score=48.8]; C2H2-type zinc finger [PF13894.8, score=33.6]; C2H2-type zinc-finger domain [PF13909.8, score=26.9]; Drought induced 19 protein (Di19), zinc-binding [PF05605.14, score=23.9]; GAGA factor [PF09237.13, score=18.9]} {Human: ENSG00000085276, MECOM, MDS1 and EVI1 complex locus, [Score=133, Expect=6e-34]; ENSG00000142611, PRDM16, PR/SET domain 16, [Score=132, Expect=8e-34]} {Mouse: ENSMUSG00000039410, Prdm16, PR domain containing 16, [Score=133, Expect=5e-34]; ENSMUSG00000027684, Mecom, MDS1 and EVI1 complex locus, [Score=133, Expect=3e-34]} {Dmel: FBgn0032707, CG10348, [Score=132, Expect=3e-34]} {Celegans: WBGene00001207, egl-43, Egl-43, [RH, Score=97.8, Expect=3e-23]} {Smed: dd_Smed_v6_22685_0_1, dd_Smed_v6_22685_0_1, [Score=134, Expect=1e-36]} {RNA1310_48534} {RNA815_4264.1} |
20. | MligTC455_26474 | 257 | 5.36 | Mlig455_023312 | Neo: Irradiation Age: Up-Down-Up Region-enriched R3: 5.747/0.00000 |
OTOG | 1.905 | - | - | - | - | 0.932 | 0.973 | Mlig455_023312 {REF} {Length: 3545} {Pfam: Cystine-knot domain [PF00007.24, score=40.6]; Trypsin Inhibitor like cysteine rich domain [PF01826.19, score=28.4]} {Human: ENSG00000188162, OTOG, otogelin, [Score=53.9, Expect=6e-07]} {Mouse: ENSMUSG00000048191, Muc6, mucin 6, gastric, [Score=50.4, Expect=4e-06]} {Smed: dd_Smed_v6_3185_0_1, dd_Smed_v6_3185_0_1, [Score=210, Expect=6e-62]} {RNA1509_42162} {RNA1310_2753} {RNA815_1083.1} |
21. | MligTC455_43728 | 1742 | 36.29 | Mlig455_031260 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.389 Region-enriched R3: 7.314/0.00000 |
1.896 | - | - | - | - | 0.967 | 0.929 | Mlig455_031260 {REF} {Length: 660} {RNA1509_4671} {RNA1310_89218} {RNA815_13649.1} | |
22. | MligTC455_22061 | 1034 | 21.54 | Mlig455_023681 | Neo: - Age: Down-Down-Up Region-specific R3: 6.421 Region-enriched R3: 6.675/0.00000 |
1.891 | - | - | - | - | 0.928 | 0.963 | Mlig455_023681 {REF} {Length: 594} {RNA1509_30789} {RNA1310_74956, RNA1509_30789} {RNA1509_30789, RNA815_42722.1} | |
23. | MligTC455_43729 | 1693 | 35.28 | Mlig455_031321 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.820 Region-enriched R3: 7.339/0.00000 |
1.886 | - | - | - | - | 0.964 | 0.922 | Mlig455_031321 {REF} {Length: 727} {RNA1509_14236, RNA1509_25603, RNA1509_4671} {RNA1310_89218, RNA1509_14236, RNA1509_25603} {RNA1509_14236, RNA1509_25603, RNA815_13649.1} | |
24. | MligTC455_10600 | 44 | 0.91 | Mlig455_000569 | Neo: - Age: - |
GRIK3 | 1.872 | - | 0.975 | - | - | 0.897 | - | Mlig455_000569 {REF} {Length: 2818} {Pfam: Ligated ion channel L-glutamate- and glycine-binding site [PF10613.11, score=74.0]; Bacterial extracellular solute-binding proteins, family 3 [PF00497.22, score=55.9]; Ligand-gated ion channel [PF00060.28, score=42.5]} {Human: ENSG00000163873, GRIK3, glutamate ionotropic receptor kainate type subunit 3, [Score=146, Expect=2e-35]; ENSG00000171189, GRIK1, glutamate ionotropic receptor kainate type subunit 1, [Score=143, Expect=2e-34]; ENSG00000164418, GRIK2, glutamate ionotropic receptor kainate type subunit 2, [Score=141, Expect=5e-34]; ENSG00000105737, GRIK5, glutamate ionotropic receptor kainate type subunit 5, [Score=139, Expect=3e-33]} {Mouse: ENSMUSG00000001985, Grik3, glutamate receptor, ionotropic, kainate 3, [Score=145, Expect=3e-35]; ENSMUSG00000056073, Grik2, glutamate receptor, ionotropic, kainate 2 (beta 2), [Score=144, Expect=6e-35]; ENSMUSG00000022935, Grik1, glutamate receptor, ionotropic, kainate 1, [Score=141, Expect=6e-34]; ENSMUSG00000032017, Grik4, glutamate receptor, ionotropic, kainate 4, [Score=140, Expect=2e-33]; ENSMUSG00000003378, Grik5, glutamate receptor, ionotropic, kainate 5 (gamma 2), [Score=139, Expect=4e-33]} {Dmel: FBgn0026255, clumsy, [Score=132, Expect=4e-31]} {Celegans: WBGene00001613, glr-2, Glutamate receptor 2, [Score=135, Expect=2e-32]} {Smed: dd_Smed_v6_14655_0_1, dd_Smed_v6_14655_0_1, [Score=155, Expect=6e-39]} {RNA1509_59839} {RNA1310_4586} {RNA815_2154.1} |
25. | MligTC455_49470 | 54 | 1.13 | Mlig455_054252 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.395 Region-enriched R3: 5.217/0.00090 |
B3GNT5 | 1.871 | - | - | - | - | 0.898 | 0.973 | Mlig455_054252 {REF} {Length: 3081} {Pfam: Galactosyltransferase [PF01762.23, score=90.8]} {Human: ENSG00000176597, B3GNT5, UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5, [Score=99.4, Expect=6e-22]} {Mouse: ENSMUSG00000034780, B3galt1, UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1, [Score=89.0, Expect=6e-19]} {Dmel: FBgn0000221, brn, brainiac, [Score=77.4, Expect=3e-15]} {Celegans: WBGene00044630, bus-17, Hexosyltransferase, [RH, Score=65.5, Expect=2e-11]} {Smed: dd_Smed_v6_13702_0_1, dd_Smed_v6_13702_0_1, [RH, Score=170, Expect=1e-47]} {RNA1509_54587} {RNA1310_18654} {RNA815_8083} |
26. | MligTC455_28589 | 1474 | 30.7 | Mlig455_021999 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=0.347 Region-enriched R3: 5.940/0.00000 |
1.864 | - | - | - | - | 0.906 | 0.958 | Mlig455_021999 {REF} {Length: 1831} {Pfam: WAP-type (Whey Acidic Protein) 'four-disulfide core' [PF00095.23, score=27.4]} {RNA1509_25631, RNA1509_9366} {RNA1310_20948, RNA1509_25631, RNA1509_9366} {RNA1509_25631, RNA1509_9366, RNA815_14415} | |
27. | MligTC455_43726 | 738 | 15.37 | Mlig455_031091, Mlig455_031126 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.725 Region-specific R3: 8.783 Region-enriched R3: 7.816/0.00000 |
1.864 | - | - | - | - | 0.969 | 0.895 | Mlig455_031091 {REF} {Length: 2108} {TRANSSPLICED} {RNA1509_10925, RNA1509_41471} {RNA1310_123716, RNA1509_10925, RNA1509_41471} {RNA1509_10925, RNA1509_41471, RNA815_13649.1} Mlig455_031126 {REF} {Length: 1113} {TRANSSPLICED} {RNA1509_25603} {RNA1310_89218} {RNA815_13649.1} |
|
28. | MligTC455_04509 | 308 | 6.42 | Mlig455_015097, Mlig455_015215 | Neo: - Age: - Region-enriched R3: 2.768/0.00001 Regeneration-downregulated BL: -7.255 Regeneration-depleted BL: -7.255 |
C1GALT1 | 1.862 | - | - | - | 0.897 | 0.965 | - | Mlig455_015097 {REF} {Length: 1363} {Pfam: Galactosyltransferase [PF01762.23, score=33.1]; Fringe-like [PF02434.18, score=32.5]} {Human: ENSG00000106392, C1GALT1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=162, Expect=2e-46]} {Mouse: ENSMUSG00000042460, C1galt1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1, [Score=165, Expect=1e-47]} {Dmel: FBgn0032078, C1GalTA, Core 1 Galactosyltransferase A, [Score=183, Expect=3e-54]} {Celegans: WBGene00008019, C38H2.2, Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=183, Expect=3e-54]} {Smed: dd_Smed_v6_4310_0_1, dd_Smed_v6_4310_0_1, [Score=188, Expect=1e-56]} {RNA1509_52982} {RNA1310_22738.1} {RNA815_21441} Mlig455_015215 {REF} {Length: 2494} {Pfam: Fringe-like [PF02434.18, score=59.2]; Galactosyltransferase [PF01762.23, score=57.8]} {Human: ENSG00000106392, C1GALT1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=175, Expect=3e-48]} {Mouse: ENSMUSG00000042460, C1galt1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1, [Score=172, Expect=1e-47]} {Dmel: FBgn0032078, C1GalTA, Core 1 Galactosyltransferase A, [Score=184, Expect=7e-52]} {Celegans: WBGene00008019, C38H2.2, Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=183, Expect=2e-51]} {Smed: dd_Smed_v6_4310_0_1, dd_Smed_v6_4310_0_1, [Score=188, Expect=8e-54]} {RNA1509_52982} {RNA1310_22738.1} {RNA815_21441} |
29. | MligTC455_48324 | 1746 | 36.38 | Mlig455_058196 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.604 Region-enriched R3: 5.386/0.00000 |
ZAN | 1.854 | - | 0.953 | - | - | - | 0.901 | Mlig455_058196 {REF} {Length: 2399} {Human: ENSG00000146839, ZAN, zonadhesin (gene/pseudogene), [Score=150, Expect=3e-37]} {Mouse: ENSMUSG00000049008, BB014433, expressed sequence BB014433, [Score=67.0, Expect=2e-11]; ENSMUSG00000079173, Zan, zonadhesin, [Score=63.9, Expect=5e-10]} {Dmel: FBgn0034294, Muc55B, Mucin 55B, [Score=109, Expect=6e-25]} {RNA1509_27445} {RNA1310_7841} {RNA815_14882.1} |
30. | MligTC455_13523 | 27 | 0.56 | Mlig455_068497 | Neo: - Age: - |
SBK1 | 1.826 | - | - | - | - | 0.874 | 0.952 | Mlig455_068497 {REF} {Length: 1384} {Pfam: Protein kinase domain [PF00069.27, score=133.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=103.2]; Kinase-like [PF14531.8, score=18.7]} {Human: ENSG00000188322, SBK1, SH3 domain binding kinase 1, [Score=242, Expect=7e-76]} {Mouse: ENSMUSG00000042978, Sbk1, SH3-binding kinase 1, [Score=242, Expect=4e-76]} {Dmel: FBgn0034137, CG4945, [RH, Score=200, Expect=8e-59]} {Celegans: WBGene00009326, F32D8.1, [Score=109, Expect=6e-27]} {Smed: dd_Smed_v6_8041_0_1, dd_Smed_v6_8041_0_1, [Score=98.6, Expect=4e-23]} {RNA1310_104030} |
31. | MligTC455_04510 | 46 | 0.96 | Mlig455_027175 | Neo: - Age: Down-Up-Up |
C1GALT1 | 1.82 | - | - | - | - | 0.953 | 0.867 | Mlig455_027175 {REF} {Length: 1524} {Pfam: Galactosyltransferase [PF01762.23, score=33.5]; Fringe-like [PF02434.18, score=32.7]} {Human: ENSG00000106392, C1GALT1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=162, Expect=2e-46]} {Mouse: ENSMUSG00000042460, C1galt1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1, [Score=164, Expect=1e-47]} {Dmel: FBgn0032078, C1GalTA, Core 1 Galactosyltransferase A, [Score=174, Expect=2e-51]} {Celegans: WBGene00008019, C38H2.2, Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=180, Expect=1e-53]} {Smed: dd_Smed_v6_4310_0_1, dd_Smed_v6_4310_0_1, [Score=187, Expect=1e-56]} {RNA1509_52982} {RNA1310_22738.1} {RNA815_21441} |
32. | MligTC455_29593 | 33 | 0.68 | Mlig455_069867 | Neo: - Age: - |
1.817 | - | - | - | - | 0.978 | 0.839 | Mlig455_069867 {REF} {Length: 1949} {RNA1310_74802.1} {RNA815_57642} | |
33. | MligTC455_26473 | 1080 | 22.49 | Mlig455_023245 | Neo: - Age: Up-Down-Down Region-enriched R3: 5.994/0.00000 |
1.815 | - | - | - | - | 0.822 | 0.993 | Mlig455_023245 {REF} {Length: 5587} {Mouse: ENSMUSG00000006014, Prg4, proteoglycan 4 (megakaryocyte stimulating factor, articular superficial zone protein), [Score=59.7, Expect=2e-08]} {RNA1509_3202} {RNA1310_2753} {RNA815_1083.1} | |
34. | MligTC455_21466 | 1733 | 36.1 | Mlig455_058501, Mlig455_058507 | Neo: - Age: Down-Up-Up Region-enriched R3: 5.835/0.00000 |
1.813 | - | 0.840 | - | - | - | 0.973 | Mlig455_058501 {REF} {Length: 1057} {RNA1509_51415, RNA1509_6162} {RNA1310_51973, RNA1509_51415, RNA1509_6162} {RNA1509_51415, RNA1509_6162, RNA815_26113} Mlig455_058507 {REF} {Length: 1051} {RNA1509_6162} {RNA1310_51973} {RNA815_26113} |
|
35. | MligTC455_15309 | 35 | 0.73 | Mlig455_065461, Mlig455_067184 | Neo: - Age: - |
FOXRED2 | 1.79 | - | - | - | 0.836 | - | 0.954 | Mlig455_065461 {REF} {Length: 2087} {Pfam: Pyridine nucleotide-disulphide oxidoreductase [PF13738.8, score=125.5]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=41.4]; L-lysine 6-monooxygenase (NADPH-requiring) [PF13434.8, score=35.0]; Pyridine nucleotide-disulphide oxidoreductase [PF00070.29, score=22.8]; FAD dependent oxidoreductase [PF01266.26, score=18.6]; HI0933-like protein [PF03486.16, score=18.6]} {Human: ENSG00000100350, FOXRED2, FAD dependent oxidoreductase domain containing 2, [Score=459, Expect=9e-154]} {Mouse: ENSMUSG00000016552, Foxred2, FAD-dependent oxidoreductase domain containing 2, [Score=457, Expect=2e-153]} {Smed: dd_Smed_v6_12138_0_1, dd_Smed_v6_12138_0_1, [RH, Score=464, Expect=5e-157]} {RNA1509_42325, RNA1509_58014} {RNA1310_12953, RNA1509_42325, RNA1509_58014} {RNA1509_42325, RNA1509_58014, RNA815_4760} Mlig455_067184 {REF} {Length: 2619} {Pfam: Pyridine nucleotide-disulphide oxidoreductase [PF13738.8, score=124.4]; Pyridine nucleotide-disulphide oxidoreductase [PF07992.16, score=40.0]; L-lysine 6-monooxygenase (NADPH-requiring) [PF13434.8, score=36.5]; Pyridine nucleotide-disulphide oxidoreductase [PF00070.29, score=21.1]; FAD-NAD(P)-binding [PF13454.8, score=20.0]} {Human: ENSG00000100350, FOXRED2, FAD dependent oxidoreductase domain containing 2, [Score=460, Expect=1e-150]} {Mouse: ENSMUSG00000016552, Foxred2, FAD-dependent oxidoreductase domain containing 2, [Score=458, Expect=3e-150]} {Smed: dd_Smed_v6_12138_0_1, dd_Smed_v6_12138_0_1, [RH, Score=467, Expect=7e-155]} {RNA1509_42325} {RNA1310_12953} {RNA815_4760} |
36. | MligTC455_28313 | 86 | 1.79 | Mlig455_046339 | Neo: - Age: - |
1.788 | - | - | - | 0.814 | 0.974 | - | Mlig455_046339 {REF} {Length: 636} {Mouse: ENSMUSG00000025272, Tro, trophinin, [Score=70.9, Expect=3e-14]} {RNA1310_66537} | |
37. | MligTC455_25885 | 15 | 0.31 | Mlig455_028596 | Neo: - Age: - |
PXDN | 1.776 | - | - | - | - | 0.821 | 0.955 | Mlig455_028596 {REF} {Length: 2436} {Pfam: Leucine rich repeat [PF13855.8, score=85.1]; Tetraspanin family [PF00335.22, score=75.1]; Leucine Rich repeats (2 copies) [PF12799.9, score=42.4]; Leucine-rich repeat [PF14580.8, score=25.7]} {Human: ENSG00000130508, PXDN, peroxidasin, [Score=65.9, Expect=8e-12]} {Mouse: ENSMUSG00000046070, Igfals, insulin-like growth factor binding protein, acid labile subunit, [Score=68.9, Expect=8e-12]} {Dmel: FBgn0029114, Tollo, [Score=71.2, Expect=2e-12]} {Celegans: WBGene00008093, lron-1, ELRR (Extracellular Leucine-Rich Repeat) ONly, [Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_6669_0_2, dd_Smed_v6_6669_0_2, [Score=85.9, Expect=2e-17]} {RNA1509_54214} {RNA1310_15547} {RNA815_8809.1} |
38. | MligTC455_19100 | 15 | 0.31 | Mlig455_025252 | Neo: - Age: - |
DAXX | 1.766 | - | - | 0.797 | - | 0.969 | - | Mlig455_025252 {REF} {Length: 4813} {TRANSSPLICED} {Human: ENSG00000231617, DAXX, death domain associated protein, [Score=108, Expect=2e-23]; ENSG00000227046, DAXX, death domain associated protein, [Score=108, Expect=2e-23]; ENSG00000204209, DAXX, death domain associated protein, [Score=108, Expect=2e-23]; ENSG00000206206, DAXX, death domain associated protein, [Score=108, Expect=2e-23]; ENSG00000206279, DAXX, death domain associated protein, [Score=108, Expect=2e-23]} {Mouse: ENSMUSG00000002307, Daxx, Fas death domain-associated protein, [Score=113, Expect=2e-25]} {Dmel: FBgn0031820, Daxx, Daxx-like protein, [Score=80.1, Expect=7e-15]} {Smed: dd_Smed_v6_12059_0_6, dd_Smed_v6_12059_0_6, [RH, Score=113, Expect=5e-26]} {RNA1509_25153} {RNA1310_7064.1} {RNA815_18101} |
39. | MligTC455_12574 | 95 | 1.98 | Mlig455_010864, Mlig455_010895 | Neo: - Age: - |
1.765 | - | - | - | - | 0.959 | 0.806 | Mlig455_010864 {REF} {Length: 886} {RNA1310_70414} {RNA815_36183} Mlig455_010895 {REF} {Length: 627} {RNA1310_70414} {RNA815_36183} |
|
40. | MligTC455_37338 | 40 | 0.84 | Mlig455_035280 | Neo: - Age: - |
1.76 | - | - | - | - | 0.965 | 0.795 | Mlig455_035280 {REF} {Length: 2442} {RNA1310_17149} {RNA815_15957} | |
41. | MligTC455_33877 | 47 | 0.97 | Mlig455_053914 | Neo: - |
PKD1L2 | 1.744 | - | - | - | - | 0.976 | 0.768 | Mlig455_053914 {REF} {Length: 11153} {Pfam: Polycystin cation channel [PF08016.14, score=263.3]; PKD domain [PF18911.2, score=78.1]; PLAT/LH2 domain [PF01477.25, score=77.6]; PKD domain [PF00801.22, score=77.5]; REJ domain [PF02010.17, score=51.1]; Ion transport protein [PF00520.33, score=32.5]} {Human: ENSG00000166473, PKD1L2, polycystin 1 like 2 (gene/pseudogene), [Score=236, Expect=4e-61]} {Mouse: ENSMUSG00000034416, Pkd1l2, polycystic kidney disease 1 like 2, [Score=254, Expect=1e-66]} {Dmel: FBgn0041195, Pkd2, Polycystic kidney disease 2, [Score=132, Expect=3e-30]} {Celegans: WBGene00003058, lov-1, Location of vulva defective 1, [Score=134, Expect=1e-30]} {Smed: dd_Smed_v6_15525_0_2, dd_Smed_v6_15525_0_2, [Score=451, Expect=4e-127]} {RNA1509_40400} {RNA1310_23183} {RNA815_27645} |
42. | MligTC455_17850 | 65 | 1.35 | Mlig455_002427 | Neo: - Age: - |
1.74 | - | - | - | - | 0.960 | 0.780 | Mlig455_002427 {REF} {Length: 474} {NoTransDecoderORF} {RNA1310_58520.2} {RNA815_36774} | |
43. | MligTC455_51256 | 668 | 13.92 | Mlig455_015101 | Neo: - Age: - Region-enriched R2: 12.900/0.00013 Regeneration-downregulated R2: -11.444 Regeneration-depleted R2: -11.444 |
1.735 | - | - | 0.780 | - | 0.955 | - | Mlig455_015101 {REF} {Length: 702} {RNA1509_53179} {RNA1310_61610.1} {RNA815_31153} | |
44. | MligTC455_31240 | 329 | 6.85 | Mlig455_010150 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.167 Region-enriched R4: 6.247/0.01251 |
1.73 | - | - | - | - | 0.962 | 0.768 | Mlig455_010150 {REF} {Length: 557} {RNA1509_16524, RNA1509_26056} {RNA1310_74791.1, RNA1509_16524} {RNA1509_16524, RNA815_37646} | |
45. | MligTC455_20900 | 185 | 3.85 | Mlig455_016663, Mlig455_056352, Mlig455_056364 | Neo: - Age: logFC(26M/2M)=0.440 Region-enriched R3: 6.081/0.00000 |
PTF1A | 1.726 | - | - | - | - | 0.745 | 0.981 | Mlig455_016663 {REF} {Length: 1779} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=69.4]} {Human: ENSG00000168267, PTF1A, pancreas associated transcription factor 1a, [RH, Score=114, Expect=2e-28]} {Mouse: ENSMUSG00000026735, Ptf1a, pancreas specific transcription factor, 1a, [RH, Score=112, Expect=5e-28]} {Dmel: FBgn0037475, Fer1, 48 related 1, [RH, Score=123, Expect=1e-32]} {Celegans: WBGene00001957, hlh-13, Helix-loop-helix protein 13, [Score=86.7, Expect=2e-20]} {Smed: dd_Smed_v6_13704_0_1, dd_Smed_v6_13704_0_1, [RH, Score=126, Expect=2e-34]} {RNA1310_22164} {RNA815_43429} Mlig455_056352 {REF} {Length: 1831} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=69.3]} {Human: ENSG00000168267, PTF1A, pancreas associated transcription factor 1a, [RH, Score=114, Expect=3e-28]} {Mouse: ENSMUSG00000026735, Ptf1a, pancreas specific transcription factor, 1a, [RH, Score=112, Expect=6e-28]} {Dmel: FBgn0037475, Fer1, 48 related 1, [RH, Score=123, Expect=1e-32]} {Celegans: WBGene00001957, hlh-13, Helix-loop-helix protein 13, [Score=86.7, Expect=2e-20]} {Smed: dd_Smed_v6_13704_0_1, dd_Smed_v6_13704_0_1, [RH, Score=126, Expect=3e-34]} {RNA1310_22164} {RNA815_43429} Mlig455_056364 {REF} {Length: 1756} {Pfam: Helix-loop-helix DNA-binding domain [PF00010.28, score=69.3]} {Human: ENSG00000168267, PTF1A, pancreas associated transcription factor 1a, [RH, Score=114, Expect=3e-28]} {Mouse: ENSMUSG00000026735, Ptf1a, pancreas specific transcription factor, 1a, [RH, Score=112, Expect=5e-28]} {Dmel: FBgn0037475, Fer1, 48 related 1, [RH, Score=124, Expect=7e-33]} {Celegans: WBGene00001957, hlh-13, Helix-loop-helix protein 13, [Score=86.7, Expect=2e-20]} {Smed: dd_Smed_v6_13704_0_1, dd_Smed_v6_13704_0_1, [RH, Score=126, Expect=3e-34]} {RNA1310_22164} {RNA815_43429} |
46. | MligTC455_50827 | 107 | 2.22 | Mlig455_037867 | Neo: - |
WSCD2 | 1.725 | - | - | - | - | 0.975 | 0.750 | Mlig455_037867 {REF} {Length: 912} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.8, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=50.4, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=53.9, Expect=4e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=53.9, Expect=2e-08]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=46.2, Expect=8e-06]} {RNA1509_59284} {RNA1310_52794.1} {RNA815_21749.1} |
47. | MligTC455_50828 | 27 | 0.57 | Mlig455_037962 | Neo: - Age: - |
WSCD2 | 1.718 | - | - | - | - | 0.968 | 0.750 | Mlig455_037962 {REF} {Length: 911} {Pfam: WSC domain [PF01822.21, score=58.4]} {Human: ENSG00000075035, WSCD2, WSC domain containing 2, [Score=52.8, Expect=1e-07]; ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=50.8, Expect=5e-07]} {Mouse: ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=53.9, Expect=3e-08]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=55.5, Expect=7e-09]} {Celegans: WBGene00005024, sqv-6, Xylosyltransferase sqv-6, [Score=46.2, Expect=8e-06]} {RNA1509_59284} {RNA1310_52794.1} {RNA815_21749.1} |
48. | MligTC455_15841 | 197 | 4.09 | Mlig455_045803, Mlig455_063182 | Neo: - Age: - |
1.714 | - | - | - | - | 0.973 | 0.741 | Mlig455_045803 {REF} {Length: 763} {RNA1310_103953} {RNA815_42645} Mlig455_063182 {REF} {Length: 773} {RNA1310_103953} {RNA815_42645} |
|
49. | MligTC455_27175 | 1238 | 25.79 | Mlig455_010169 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.628 Region-enriched R3: 6.302/0.00000 |
1.706 | - | 0.954 | - | - | - | 0.752 | Mlig455_010169 {REF} {Length: 446} {RNA1509_20242} {RNA1310_91812.1} {RNA815_23606.3} | |
50. | MligTC455_16780 | 59 | 1.22 | Mlig455_003112, Mlig455_062777 | Neo: - Age: - |
1.701 | - | - | - | - | 0.974 | 0.727 | Mlig455_003112 {REF} {Length: 1644} {Pfam: PAN domain [PF14295.8, score=23.1]} {RNA1509_48973} {RNA1310_82250} {RNA815_43010} Mlig455_062777 {REF} {Length: 1721} {RNA1509_48973} {RNA1310_82250} {RNA815_43010} |
|
51. | MligTC455_28992 | 248 | 5.17 | Mlig455_007574 | Neo: - Age: - Region-enriched R3: 5.359/0.00013 |
SIX1 | 1.676 | - | - | - | - | 0.721 | 0.955 | Mlig455_007574 {REF} {Length: 2756} {Pfam: Transcriptional regulator, SIX1, N-terminal SD domain [PF16878.7, score=146.3]; Homeodomain [PF00046.31, score=56.2]; Homeobox KN domain [PF05920.13, score=49.9]} {Human: ENSG00000126778, SIX1, SIX homeobox 1, [Score=313, Expect=9e-104]; ENSG00000170577, SIX2, SIX homeobox 2, [Score=307, Expect=3e-101]} {Mouse: ENSMUSG00000051367, Six1, sine oculis-related homeobox 1, [Score=313, Expect=5e-104]; ENSMUSG00000024134, Six2, sine oculis-related homeobox 2, [Score=308, Expect=1e-101]} {Dmel: FBgn0003460, so, sine oculis, [Score=303, Expect=3e-98]} {Celegans: WBGene00000454, ceh-33, Homeobox protein ceh-33, [RH, Score=246, Expect=2e-78]} {Smed: dd_Smed_v6_15436_0_1, dd_Smed_v6_15436_0_1, [RH, Score=326, Expect=2e-106]} {RNA1509_55511} {RNA1310_27700, RNA1509_55511} {RNA1509_55511, RNA815_16067} |
52. | MligTC455_21034 | 1691 | 35.23 | Mlig455_010768 | Neo: - Age: - Region-specific R2: 2.955 Region-enriched R2: 1.870/0.00164 |
1.657 | - | - | 0.701 | - | - | 0.956 | Mlig455_010768 {REF} {Length: 608} {TRANSSPLICED} {RNA1509_10110} {RNA1310_54235.1, RNA1509_10110} {RNA1509_10110, RNA815_27381.1} | |
53. | MligTC455_02222 | 1 | 0.03 | Mlig455_020639 | Neo: - Age: - |
0.994 | - | - | - | - | 0.994 | - | Mlig455_020639 {REF} {Length: 1013} {Pfam: Innexin [PF00876.20, score=82.5]} {Celegans: WBGene00002135, inx-13, Innexin, [Score=75.9, Expect=4e-15]} {Smed: dd_Smed_v6_13392_0_1, dd_Smed_v6_13392_0_1, [Score=75.5, Expect=5e-15]} {RNA1509_8096} {RNA1310_35430} {RNA815_42044} | |
54. | MligTC455_11699 | 122 | 2.54 | Mlig455_055861 | Neo: - Age: - Region-enriched R2: 11.336/0.00038 Regeneration-downregulated R2: -9.399 Regeneration-depleted R2: -9.399 |
0.992 | - | - | - | - | 0.992 | - | Mlig455_055861 {REF} {Length: 601} {RNA1509_1258} {RNA1310_120080} {RNA815_53081} | |
55. | MligTC455_33936 | 62 | 1.29 | Mlig455_061181 | Neo: - Age: Down-Down-Up Region-enriched R3: 4.766/0.00000 |
0.991 | - | - | - | - | - | 0.991 | Mlig455_061181 {REF} {Length: 2443} {Pfam: Fibronectin type II domain [PF00040.21, score=54.5]} {Mouse: ENSMUSG00000054580, Pla2r1, phospholipase A2 receptor 1, [Score=50.1, Expect=2e-06]} {RNA1310_23349.1} {RNA815_44226.1} | |
56. | MligTC455_23857 | 179 | 3.73 | Mlig455_011373 | Neo: - Age: - |
KCNN2 | 0.984 | - | - | - | - | 0.984 | - | Mlig455_011373 {REF} {Length: 4119} {Pfam: Calcium-activated SK potassium channel [PF03530.16, score=144.8]; Calmodulin binding domain [PF02888.18, score=112.8]; Ion channel [PF07885.18, score=51.5]} {Human: ENSG00000080709, KCNN2, potassium calcium-activated channel subfamily N member 2, [RH, Score=541, Expect=4e-180]; ENSG00000143603, KCNN3, potassium calcium-activated channel subfamily N member 3, [RH, Score=534, Expect=5e-179]; ENSG00000105642, KCNN1, potassium calcium-activated channel subfamily N member 1, [RH, Score=514, Expect=4e-174]} {Mouse: ENSMUSG00000054477, Kcnn2, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2, [RH, Score=543, Expect=0.0]; ENSMUSG00000000794, Kcnn3, potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3, [RH, Score=533, Expect=7e-179]} {Dmel: FBgn0029761, SK, small conductance calcium-activated potassium channel, [RH, Score=602, Expect=0.0]} {Celegans: WBGene00008570, kcnl-2, KCNL-2 variant; KCNN (Potassium K ChaNNel, calcium activated)-Like, [RH, Score=428, Expect=5e-137]} {Smed: dd_Smed_v6_14006_0_1, dd_Smed_v6_14006_0_1, [RH, Score=552, Expect=0.0]} {RNA1509_39011, RNA1509_39273} {RNA1310_12409, RNA1509_39011, RNA1509_39273} {RNA1509_39011, RNA1509_39273, RNA815_5551} |
57. | MligTC455_19795 | 50 | 1.05 | Mlig455_015163, Mlig455_015285 | Neo: - Age: Up-Down-Down |
0.983 | - | - | - | - | - | 0.983 | Mlig455_015163 {REF} {Length: 4537} {TRANSSPLICED} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.2]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=366, Expect=7e-119]} {RNA1509_44797} {RNA1310_13221} {RNA815_45407} Mlig455_015285 {REF} {Length: 4094} {TRANSSPLICED} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Smed: dd_Smed_v6_23771_0_1, dd_Smed_v6_23771_0_1, [RH, Score=366, Expect=9e-119]} {RNA1509_57431} {RNA1310_13221} {RNA815_45407} |
|
58. | MligTC455_24596 | 18 | 0.38 | Mlig455_007754, Mlig455_053490 | Neo: - Age: - |
0.983 | - | - | - | - | 0.983 | - | Mlig455_007754 {REF} {Length: 248} {NoTransDecoderORF} {RNA1509_48697} {RNA1310_71854} {RNA815_131.1} Mlig455_053490 {REF} {Length: 302} {NoTransDecoderORF} {RNA1509_48697} {RNA1310_71854} {RNA815_131.1} |
|
59. | MligTC455_27615 | 45 | 0.93 | Mlig455_004284 | Neo: - Age: - |
0.983 | - | - | - | - | 0.983 | - | Mlig455_004284 {REF} {Length: 4466} {TRANSSPLICED} {Pfam: Wolframin cysteine-rich domain [PF20053.1, score=73.4]; Wolframin C-terminal OB-fold domain [PF19913.1, score=32.7]} {RNA1509_20192, RNA1509_56105} {RNA1310_15643, RNA1509_56105} {RNA1509_56105, RNA815_12266} | |
60. | MligTC455_08423 | 2 | 0.05 | Mlig455_008615 | Neo: - Age: - |
0.982 | - | - | - | - | 0.982 | - | Mlig455_008615 {REF} {Length: 1229} {Pfam: Ubiquitin carboxyl-terminal hydrolase [PF00443.31, score=32.1]; Ubiquitin carboxyl-terminal hydrolase [PF13423.8, score=30.8]} {RNA1509_39699} {RNA1310_23460} {RNA815_38515} | |
61. | MligTC455_57506 | 4 | 0.08 | Mlig455_054204 | Neo: - Age: - |
0.981 | - | - | - | - | 0.981 | - | Mlig455_054204 {REF} {Length: 300} {Pfam: Integrase core domain [PF00665.28, score=57.6]} {Smed: dd_Smed_v6_4052_0_1, dd_Smed_v6_4052_0_1, [Score=71.6, Expect=9e-18]} {RNA1310_95238} {RNA815_41366} | |
62. | MligTC455_00360 | 3 | 0.06 | Mlig455_003350 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_003350 {REF} {Length: 572} {NoTransDecoderORF} {RNA1509_37106} {RNA1310_20119} {RNA815_32661} | |
63. | MligTC455_00893 | 1 | 0.02 | Mlig455_044599 | Neo: - Age: - |
CUBN | 0.978 | - | - | - | - | 0.978 | - | Mlig455_044599 {REF} {Length: 872} {Pfam: CUB domain [PF00431.22, score=55.3]} {Human: ENSG00000107611, CUBN, cubilin, [Score=58.2, Expect=3e-09]} {Mouse: ENSMUSG00000026726, Cubn, cubilin (intrinsic factor-cobalamin receptor), [Score=53.1, Expect=9e-08]} {Smed: dd_Smed_v6_69474_0_1, dd_Smed_v6_69474_0_1, [Score=44.3, Expect=3e-06]} {RNA1310_66805} |
64. | MligTC455_01855 | 5 | 0.1 | Mlig455_019884 | Neo: Germline Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_019884 {REF} {Length: 837} {RNA1310_46030.1} {RNA815_34666} | |
65. | MligTC455_01972 | 8 | 0.17 | Mlig455_065411 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_065411 {REF} {Length: 646} {RNA1310_149608} | |
66. | MligTC455_02383 | 3 | 0.07 | Mlig455_006775 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_006775 {REF} {Length: 1124} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=95.1]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=86.3]; Aspartyl protease [PF13650.8, score=20.6]; gag-polyprotein putative aspartyl protease [PF13975.8, score=19.6]} {Smed: dd_Smed_v6_15498_0_18, dd_Smed_v6_15498_0_18, [Score=79.3, Expect=2e-16]} {RNA1509_44038} {RNA1310_11212} {RNA815_45036} | |
67. | MligTC455_03210 | 1 | 0.02 | Mlig455_026190 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_026190 {REF} {Length: 673} {NoTransDecoderORF} | |
68. | MligTC455_03368 | 10 | 0.21 | Mlig455_056536 | Neo: - Age: - |
HTR3A | 0.978 | - | - | - | - | 0.978 | - | Mlig455_056536 {REF} {Length: 1346} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=109.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=82.9]} {Human: ENSG00000166736, HTR3A, 5-hydroxytryptamine receptor 3A, [Score=132, Expect=1e-33]; ENSG00000129749, CHRNA10, cholinergic receptor nicotinic alpha 10 subunit, [Score=126, Expect=1e-31]} {Mouse: ENSMUSG00000032269, Htr3a, 5-hydroxytryptamine (serotonin) receptor 3A, [Score=137, Expect=3e-35]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=122, Expect=5e-30]} {Celegans: WBGene00000048, acr-9, AcetylCholine Receptor, [Score=137, Expect=2e-35]} {Smed: dd_Smed_v6_23922_0_1, dd_Smed_v6_23922_0_1, [Score=126, Expect=1e-31]} {RNA1509_7752} {RNA1310_1750.2} {RNA815_6234} |
69. | MligTC455_03483 | 14 | 0.29 | Mlig455_004066, Mlig455_004118, Mlig455_060442 | Neo: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_004066 {REF} {Length: 399} {NoTransDecoderORF} {RNA1509_9966} {RNA1310_27634} {RNA815_4490.1} Mlig455_004118 {REF} {Length: 567} {NoTransDecoderORF} {RNA1509_9966} {RNA1310_12692.1} {RNA815_4490.1} Mlig455_060442 {REF} {Length: 536} {NoTransDecoderORF} {RNA1509_9966} {RNA1310_12692.1} {RNA815_4490.1} |
|
70. | MligTC455_04465 | 2 | 0.04 | Mlig455_019145 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_019145 {REF} {Length: 352} {NoTransDecoderORF} {RNA1310_89330} | |
71. | MligTC455_04679 | 2 | 0.04 | Mlig455_058054 | Neo: - Age: Up-Down-Down |
0.978 | - | - | - | - | 0.978 | - | Mlig455_058054 {REF} {Length: 1496} {Pfam: Glycosyltransferase sugar-binding region containing DXD motif [PF04488.17, score=50.2]} {Smed: dd_Smed_v6_9783_0_1, dd_Smed_v6_9783_0_1, [Score=92.4, Expect=1e-20]} {RNA1509_4484} {RNA1310_25467} {RNA815_39314} | |
72. | MligTC455_05305 | 1 | 0.03 | Mlig455_021332 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_021332 {REF} {Length: 354} {NoTransDecoderORF} | |
73. | MligTC455_05413 | 5 | 0.1 | Mlig455_009332 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_009332 {REF} {Length: 473} {NoTransDecoderORF} {RNA1509_17823} {RNA1310_43999} {RNA815_18130} | |
74. | MligTC455_05756 | 6 | 0.12 | Mlig455_005000 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_005000 {REF} {Length: 299} {NoTransDecoderORF} {RNA1310_141322} | |
75. | MligTC455_05804 | 5 | 0.11 | Mlig455_012115 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_012115 {REF} {Length: 533} {NoTransDecoderORF} {RNA1310_54712.2} {RNA815_20004.2} | |
76. | MligTC455_05866 | 26 | 0.54 | Mlig455_003192, Mlig455_026798 | Neo: - Age: - Region-enriched R4: 5.964/0.03025 |
0.978 | - | - | - | - | 0.978 | - | Mlig455_003192 {REF} {Length: 393} {NoTransDecoderORF} {RNA1509_44471} {RNA1310_75127.2} {RNA815_51525} Mlig455_026798 {REF} {Length: 556} {NoTransDecoderORF} {RNA1310_75127.2} {RNA815_51525} |
|
77. | MligTC455_06143 | 5 | 0.11 | Mlig455_064395 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_064395 {REF} {Length: 727} {RNA1509_58025} {RNA1310_20554} {RNA815_7470.1} | |
78. | MligTC455_06604 | 25 | 0.52 | Mlig455_020786 | Neo: - |
KREMEN1 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_020786 {REF} {Length: 1762} {Pfam: WSC domain [PF01822.21, score=65.2]} {Human: ENSG00000183762, KREMEN1, kringle containing transmembrane protein 1, [Score=56.2, Expect=3e-09]} {Mouse: ENSMUSG00000020393, Kremen1, kringle containing transmembrane protein 1, [Score=58.5, Expect=3e-10]} {RNA1509_36914, RNA1509_47848} {RNA1310_9932.1, RNA1509_47848} {RNA1509_47848, RNA815_31064} |
79. | MligTC455_06679 | 3 | 0.07 | Mlig455_051102 | Neo: - Age: - |
SLC7A1 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_051102 {REF} {Length: 1849} {Pfam: Amino acid permease [PF13520.8, score=121.8]; Amino acid permease [PF00324.23, score=104.4]; C-terminus of AA_permease [PF13906.8, score=56.3]} {Human: ENSG00000139514, SLC7A1, solute carrier family 7 member 1, [Score=289, Expect=3e-89]; ENSG00000003989, SLC7A2, solute carrier family 7 member 2, [Score=280, Expect=1e-85]; ENSG00000099960, SLC7A4, solute carrier family 7 member 4, [Score=278, Expect=5e-85]} {Mouse: ENSMUSG00000022756, Slc7a4, solute carrier family 7 (cationic amino acid transporter, y+ system), member 4, [Score=294, Expect=4e-91]; ENSMUSG00000041313, Slc7a1, solute carrier family 7 (cationic amino acid transporter, y+ system), member 1, [Score=292, Expect=2e-90]; ENSMUSG00000054753, AU018091, expressed sequence AU018091, [Score=288, Expect=1e-88]; ENSMUSG00000107871, AU018091, expressed sequence AU018091, [Score=288, Expect=1e-88]} {Dmel: FBgn0036984, CG13248, [Score=296, Expect=1e-91]} {Celegans: WBGene00016806, C50D2.2, [Score=296, Expect=1e-92]} {Smed: dd_Smed_v6_8652_0_8, dd_Smed_v6_8652_0_8, [Score=436, Expect=3e-147]} {RNA1310_82370} {RNA815_51664} |
80. | MligTC455_06723 | 4 | 0.09 | Mlig455_029808, Mlig455_034904 | Neo: - Age: - |
ARHGAP39 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_029808 {REF} {Length: 738} {Pfam: WW domain [PF00397.28, score=28.3]} {Human: ENSG00000147799, ARHGAP39, Rho GTPase activating protein 39, [Score=94.7, Expect=4e-22]} {Mouse: ENSMUSG00000033697, Arhgap39, Rho GTPase activating protein 39, [RH, Score=92.0, Expect=1e-23]} {Dmel: FBgn0038853, RhoGAP93B, Rho GTPase activating protein at 93B, [Score=92.4, Expect=1e-21]} {Celegans: WBGene00022367, Y92H12BM.1, [Score=90.9, Expect=2e-22]} {Smed: dd_Smed_v6_5836_0_1, dd_Smed_v6_5836_0_1, [Score=65.1, Expect=2e-12]} {RNA1310_92124} {RNA815_58680} Mlig455_034904 {REF} {Length: 707} {Pfam: WW domain [PF00397.28, score=28.9]} {Human: ENSG00000147799, ARHGAP39, Rho GTPase activating protein 39, [Score=94.0, Expect=4e-22]} {Mouse: ENSMUSG00000033697, Arhgap39, Rho GTPase activating protein 39, [RH, Score=91.7, Expect=6e-24]} {Dmel: FBgn0038853, RhoGAP93B, Rho GTPase activating protein at 93B, [Score=92.4, Expect=8e-22]} {Celegans: WBGene00022367, Y92H12BM.1, [Score=90.9, Expect=1e-22]} {Smed: dd_Smed_v6_5836_0_1, dd_Smed_v6_5836_0_1, [Score=65.1, Expect=1e-12]} {RNA1310_92124} {RNA815_58680} |
81. | MligTC455_06894 | 6 | 0.12 | Mlig455_032458 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_032458 {REF} {Length: 2789} {RNA1509_57110} {RNA1310_20410, RNA1509_57110} {RNA1509_57110, RNA815_19103} | |
82. | MligTC455_07515 | 13 | 0.27 | Mlig455_048357 | Neo: - Age: - |
HCRTR1 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_048357 {REF} {Length: 1740} {Pfam: Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=51.8]; 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=38.9]} {Human: ENSG00000121764, HCRTR1, hypocretin receptor 1, [Score=49.7, Expect=6e-06]} {Mouse: ENSMUSG00000028778, Hcrtr1, hypocretin (orexin) receptor 1, [Score=49.7, Expect=4e-06]} {Dmel: FBgn0029723, Proc-R, Proctolin receptor, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_27761_0_1, dd_Smed_v6_27761_0_1, [Score=103, Expect=3e-24]} {RNA1509_33416} {RNA1310_68701} |
83. | MligTC455_08857 | 29 | 0.61 | Mlig455_009086 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_009086 {REF} {Length: 561} {RNA1310_27547} {RNA815_16487} | |
84. | MligTC455_09359 | 17 | 0.35 | Mlig455_059675 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_059675 {REF} {Length: 522} {NoTransDecoderORF} {RNA1310_149181} | |
85. | MligTC455_09474 | 3 | 0.05 | Mlig455_007677 | Neo: - Age: - |
C1GALT1 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_007677 {REF} {Length: 1547} {Pfam: Galactosyltransferase [PF01762.23, score=27.6]} {Human: ENSG00000106392, C1GALT1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=161, Expect=2e-46]} {Mouse: ENSMUSG00000042460, C1galt1, core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1, [Score=162, Expect=7e-47]} {Dmel: FBgn0032078, C1GalTA, Core 1 Galactosyltransferase A, [Score=139, Expect=6e-38]} {Celegans: WBGene00008019, C38H2.2, Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1, [Score=165, Expect=4e-48]} {Smed: dd_Smed_v6_4310_0_1, dd_Smed_v6_4310_0_1, [Score=186, Expect=3e-56]} {RNA1310_125941} |
86. | MligTC455_09527 | 9 | 0.19 | Mlig455_003833 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_003833 {REF} {Length: 456} {RNA1310_99936} {RNA815_40952} | |
87. | MligTC455_10153 | 61 | 1.27 | Mlig455_068250, Mlig455_068270 | Neo: - Age: - |
ERBB4 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_068250 {REF} {Length: 5331} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=269.3]; Protein kinase domain [PF00069.27, score=110.9]; Receptor L domain [PF01030.26, score=51.2]; Growth factor receptor domain IV [PF14843.8, score=47.2]; Furin-like cysteine rich region [PF00757.22, score=45.7]} {Human: ENSG00000178568, ERBB4, erb-b2 receptor tyrosine kinase 4, [Score=307, Expect=1e-85]; ENSG00000146648, EGFR, epidermal growth factor receptor, [Score=296, Expect=1e-82]} {Mouse: ENSMUSG00000062209, Erbb4, erb-b2 receptor tyrosine kinase 4, [Score=309, Expect=2e-86]; ENSMUSG00000020122, Egfr, epidermal growth factor receptor, [Score=295, Expect=4e-82]} {Dmel: FBgn0003731, Egfr, Epidermal growth factor receptor, [Score=311, Expect=7e-87]} {Celegans: WBGene00002299, let-23, Receptor tyrosine-protein kinase let-23, [Score=209, Expect=2e-54]} {Smed: dd_Smed_v6_11310_0_1, dd_Smed_v6_11310_0_1, [Score=303, Expect=3e-84]} {RNA1509_1271} {RNA1310_65071} {RNA815_42809} Mlig455_068270 {REF} {Length: 5369} {Pfam: Protein tyrosine and serine/threonine kinase [PF07714.19, score=271.6]; Protein kinase domain [PF00069.27, score=111.6]} {Human: ENSG00000178568, ERBB4, erb-b2 receptor tyrosine kinase 4, [Score=303, Expect=3e-89]; ENSG00000146648, EGFR, epidermal growth factor receptor, [Score=293, Expect=7e-86]} {Mouse: ENSMUSG00000062209, Erbb4, erb-b2 receptor tyrosine kinase 4, [Score=305, Expect=4e-90]; ENSMUSG00000020122, Egfr, epidermal growth factor receptor, [Score=291, Expect=2e-85]} {Dmel: FBgn0003731, Egfr, Epidermal growth factor receptor, [Score=288, Expect=5e-84]} {Celegans: WBGene00002299, let-23, Receptor tyrosine-protein kinase let-23, [Score=207, Expect=3e-56]} {Smed: dd_Smed_v6_11310_0_1, dd_Smed_v6_11310_0_1, [Score=300, Expect=5e-88]} {RNA1509_1271} {RNA1310_65071} {RNA815_42809} |
88. | MligTC455_10341 | 15 | 0.32 | Mlig455_012927 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_012927 {REF} {Length: 697} {RNA1509_52329} {RNA1310_58743.2} {RNA815_30339} | |
89. | MligTC455_10487 | 2 | 0.04 | Mlig455_014098 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_014098 {REF} {Length: 160} {NoTransDecoderORF} {RNA1310_83952} | |
90. | MligTC455_10618 | 9 | 0.18 | Mlig455_070725 | Neo: - Age: - |
ZNF20 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_070725 {REF} {Length: 1704} {Pfam: Zinc-finger double domain [PF13465.8, score=36.3]; Zinc finger, C2H2 type [PF00096.28, score=25.2]; C2H2-type zinc finger [PF13894.8, score=20.1]} {Human: ENSG00000132010, ZNF20, zinc finger protein 20, [Score=67.8, Expect=5e-12]; ENSG00000144026, ZNF514, zinc finger protein 514, [Score=65.9, Expect=2e-11]; ENSG00000136866, ZFP37, ZFP37 zinc finger protein, [Score=65.9, Expect=3e-11]; ENSG00000102974, CTCF, CCCTC-binding factor, [Score=65.5, Expect=4e-11]} {Mouse: ENSMUSG00000102030, Gm29106, predicted gene 29106, [Score=70.1, Expect=8e-13]} {Dmel: FBgn0003567, su(Hw), suppressor of Hairy wing, [Score=64.7, Expect=3e-11]} {Celegans: WBGene00006492, let-391, [Score=63.2, Expect=6e-11]} {Smed: dd_Smed_v6_15745_0_1, dd_Smed_v6_15745_0_1, [RH, Score=122, Expect=8e-34]} {RNA1310_53462} |
91. | MligTC455_11102 | 4 | 0.08 | Mlig455_058382 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_058382 {REF} {Length: 696} | |
92. | MligTC455_11286 | 3 | 0.06 | Mlig455_034416 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_034416 {REF} {Length: 1654} {NoTransDecoderORF} {RNA1310_86650} {RNA815_19306} | |
93. | MligTC455_11354 | 2 | 0.05 | Mlig455_018374 | Neo: - Age: - |
AC079594.2 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_018374 {REF} {Length: 2356} {Pfam: RING-type zinc-finger [PF13445.8, score=36.5]; Ring finger domain [PF13639.8, score=36.0]; Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=34.7]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=34.0]; zinc finger of C3HC4-type, RING [PF15227.8, score=32.4]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=32.2]; zinc-RING finger domain [PF14634.8, score=27.2]; RING-H2 zinc finger domain [PF12678.9, score=22.1]; RING/Ubox like zinc-binding domain [PF14570.8, score=20.5]} {Human: ENSG00000248710, AC079594.2, novel tripartite motif-containing 59 (TRIM59) and intraflagellar transport 80 homolog (Chlamydomonas) (IFT80) protein, [Score=59.7, Expect=5e-09]; ENSG00000156463, SH3RF2, SH3 domain containing ring finger 2, [Score=59.7, Expect=4e-09]; ENSG00000213186, TRIM59, tripartite motif containing 59, [Score=57.4, Expect=9e-10]} {Mouse: ENSMUSG00000057719, Sh3rf2, SH3 domain containing ring finger 2, [Score=63.2, Expect=3e-10]} {Dmel: FBgn0040294, POSH, Plenty of SH3s, [Score=53.9, Expect=2e-07]} {Celegans: WBGene00003597, nhl-1, RING finger protein nhl-1, [Score=48.9, Expect=4e-06]} {Smed: dd_Smed_v6_6290_0_1, dd_Smed_v6_6290_0_1, [Score=48.5, Expect=4e-06]} {RNA1310_52131} {RNA815_43681} |
94. | MligTC455_11377 | 4 | 0.09 | Mlig455_022382 | Neo: - Age: - |
KREMEN2 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_022382 {REF} {Length: 838} {Pfam: WSC domain [PF01822.21, score=47.5]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [Score=52.4, Expect=2e-07]; ENSG00000075035, WSCD2, WSC domain containing 2, [Score=50.8, Expect=6e-07]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [Score=54.3, Expect=3e-08]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=53.1, Expect=6e-08]} {RNA1310_112537} {RNA815_23500} |
95. | MligTC455_11537 | 2 | 0.05 | Mlig455_041467 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_041467 {REF} {Length: 326} | |
96. | MligTC455_11713 | 8 | 0.16 | Mlig455_030060 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_030060 {REF} {Length: 1189} {RNA1310_40798} {RNA815_26160} | |
97. | MligTC455_11755 | 5 | 0.11 | Mlig455_018946 | Neo: - Age: - |
GRM5 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_018946 {REF} {Length: 1559} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=93.6]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=41.7]} {Human: ENSG00000168959, GRM5, glutamate metabotropic receptor 5, [Score=143, Expect=3e-36]} {Mouse: ENSMUSG00000049583, Grm5, glutamate receptor, metabotropic 5, [Score=140, Expect=2e-35]} {Dmel: FBgn0019985, mGluR, metabotropic Glutamate Receptor, [Score=131, Expect=1e-32]} {Celegans: WBGene00021152, mgl-3, Metabotropic GLutamate receptor family, [Score=98.6, Expect=6e-22]} {Smed: dd_Smed_v6_15419_0_1, dd_Smed_v6_15419_0_1, [Score=123, Expect=4e-30]} {RNA1310_98186} |
98. | MligTC455_11934 | 8 | 0.16 | Mlig455_008593, Mlig455_008607 | Neo: - Age: - |
GALR2 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_008593 {REF} {Length: 1678} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=148.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=26.6]; Serpentine type 7TM GPCR chemoreceptor Sru [PF10322.11, score=19.9]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=145, Expect=3e-39]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=136, Expect=4e-36]} {Dmel: FBgn0036789, AstC-R2, Allatostatin C receptor 2, [Score=107, Expect=4e-25]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=100, Expect=6e-23]} {Smed: dd_Smed_v6_15151_0_1, dd_Smed_v6_15151_0_1, [RH, Score=244, Expect=7e-77]} Mlig455_008607 {REF} {Length: 1678} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=148.1]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=26.6]; Serpentine type 7TM GPCR chemoreceptor Sru [PF10322.11, score=19.9]} {Human: ENSG00000182687, GALR2, galanin receptor 2, [Score=145, Expect=3e-39]} {Mouse: ENSMUSG00000020793, Galr2, galanin receptor 2, [Score=136, Expect=4e-36]} {Dmel: FBgn0036789, AstC-R2, Allatostatin C receptor 2, [Score=107, Expect=4e-25]} {Celegans: WBGene00013974, npr-9, Galanin-like G-protein coupled receptor npr-9, [Score=100, Expect=6e-23]} {Smed: dd_Smed_v6_15151_0_1, dd_Smed_v6_15151_0_1, [RH, Score=244, Expect=7e-77]} |
99. | MligTC455_12472 | 8 | 0.17 | Mlig455_008386 | Neo: - Age: - |
0.978 | - | - | - | - | 0.978 | - | Mlig455_008386 {REF} {Length: 1982} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=59.1]} {Smed: dd_Smed_v6_18754_0_1, dd_Smed_v6_18754_0_1, [Score=118, Expect=2e-29]} | |
100. | MligTC455_12683 | 4 | 0.08 | Mlig455_013681 | Neo: - Age: - |
CASKIN1 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_013681 {REF} {Length: 1211} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=125.4]; Ankyrin repeats (many copies) [PF13637.8, score=124.7]; Ankyrin repeat [PF00023.32, score=101.7]; Ankyrin repeats (many copies) [PF13857.8, score=98.5]; Ankyrin repeat [PF13606.8, score=97.6]} {Human: ENSG00000167971, CASKIN1, CASK interacting protein 1, [Score=174, Expect=4e-47]; ENSG00000177303, CASKIN2, CASK interacting protein 2, [Score=172, Expect=2e-46]} {Mouse: ENSMUSG00000033597, Caskin1, CASK interacting protein 1, [Score=174, Expect=2e-47]; ENSMUSG00000034471, Caskin2, CASK-interacting protein 2, [Score=169, Expect=1e-45]} {Dmel: FBgn0039075, CG4393, [Score=122, Expect=1e-29]} {Celegans: WBGene00006616, trp-4, TRP (Transient receptor potential) channel family, [Score=102, Expect=4e-23]} {Smed: dd_Smed_v6_2072_0_26, dd_Smed_v6_2072_0_26, [Score=110, Expect=4e-26]} {RNA1310_1281} |